Moxetumomab pasudotox and OxyIR
Determining the interaction of Moxetumomab pasudotox and OxyIR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: oxycodone
Brand name: OxyIR, Roxicodone, Roxybond, Oxaydo, Oxycontin, Oxyfast, Xtampza ER, Oxecta, Oxycontin, Roxybond, Xtampza ER; oxycodone is also present in the following combination drugs: Combunox, Endocet, Endodan, Moxduo, Oxycodan, Percocet, Percodan, Primlev, Roxicet, Xartemis XR, and others
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Oxymetazoline Hydrochloride
- Moxetumomab pasudotox-Oxymetazoline Hydrochloride topical
- Moxetumomab pasudotox-Oxymetazoline nasal
- Moxetumomab pasudotox-Oxymetazoline ophthalmic
- Moxetumomab pasudotox-Oxymetazoline topical
- Moxetumomab pasudotox-Oxymetazoline Topical application
- OxyIR-Moxetumomab Pasudotox-tdfk
- OxyIR-Moxetumomab pasudotox-tdfk Intravenous
- OxyIR-Moxifloxacin
- OxyIR-Moxifloxacin (Systemic)
- OxyIR-Moxifloxacin Hydrochloride
- OxyIR-Moxifloxacin Injection